Exelixis
EXEL
#1718
Rank
C$17.50 B
Marketcap
C$69.64
Share price
-1.89%
Change (1 day)
17.87%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company